- Home
- /
- GHK-Cu 100mg
GHK-Cu 100mg
Certificate of Analysis
HPLC + Mass Spectrometry included with order
GHK-Cu at the premium 100mg per vial research dosage — double the concentration of our 50mg variant. This high-dose format is designed for researchers requiring larger quantities per reconstitution, reducing preparation frequency in extended research protocols.
GHK-Cu is a naturally occurring copper tripeptide that declines with age and has been studied extensively for its role in tissue remodelling, gene expression modulation, and wound healing. Published research suggests it influences over 4,000 human genes involved in repair processes.
The 100mg vial represents the highest available injectable-grade GHK-Cu dosage in the UK research market — an exclusive product through our WKC supply partnership.
Independently Verified Purity: 99.578%
Tested by Janoshik Analytical (Prague) — Task #95743, 31 December 2025.
Actual content: 102.23mg per vial (2% overfilled vs stated 100mg dose).
This is a 100mg PER VIAL product.
Verification: janoshik.com/verify — Key:
9SMFNQGB84WF
Specifications
| Molecular Weight | 403.93 g/mol |
| CAS | 49557-75-7 |
| Sequence | Gly-His-Lys:Cu(II) |
| Dose | 100mg per vial |
| UK Exclusive | Highest available injectable-grade GHK-Cu dosage in the UK |
| Appearance | Blue lyophilised powder |
| Storage | 2-8°C, protect from light |
This product is sold strictly for in-vitro research and laboratory purposes. Not for human or animal consumption. Not evaluated by the MHRA or FDA. Must be 18+ to purchase. By purchasing, you agree to our Research Disclaimer and Terms of Service.
| Catalogue Number | KYR-GHKCU100MG |
| Compound Name | GHK-Cu 100mg |